Skip to main content
. 2017 Nov 13;17(15):1–167.

Table 2c:

Results of Economic Literature Review—Summary: Cost-Effectiveness of Outpatient Models of Care for Providing In-Person CBT for the Treatment of Major Depressive Disorder and/or Generalized Anxiety Disorder

Name, Year, Location Study Design and Perspective Population and Comparator Interventions Results
Health Outcomes Costs Cost-Effectiveness
Brown et al, 2011, United Kingdom57
  • Type of economic analysis: individual-level cost-minimization analysis

  • Study design: prospective cohort study, participants of a large mental health trust/specialist national psychotherapy service

  • Perspective: UK NHS

  • Time horizon: 3 months

  • Discount rate: 0%

  • Adults aged 17 years+ (mean age, intervention vs. control: 36.8 [SD: 10.1] vs. 44.9 [SD: 10.1] years) with MDD

  • Total N: 93

  • Females (%): 73%

  • Cohort divided into 2 groups based on clinician referral

  • On average, participants had lived 16+ years depression, with 2–3 medications

  • Intervention: Individual face-to-face CBT (n = 49)

  • Control: group CBT (n = 44)

  • CBT: individual, 6–18 weekly sessions; group, 10–12 weekly sessions with 8–12 participants

  • Total QALYs (mean/person): NR

  • Individual and group CBT equally effective in clinical outcomes

  • Currency, cost year: £, 2005

  • Total costs, individual vs. group CBT: £622 (SD: 271) vs. £737 (SD: 271)

  • Mean difference: £115 (P = .30)

  • Study treatment costs, individual vs. group CBT: £456.7 (SD: 190) vs. £283.5 (SD: 79; P = .001)

  • Base case analysis: no differences in total costs (including both treatment and support costs) between group and individual CBT

Vos et al, 2005, Australia56
  • Type of economic analysis: cost-effectiveness analysis

  • Study design: decision analytic (modelling) analysis

  • Perspective: Australia, health system perspective including indirect costs

  • Time horizon: 5 years

  • Discount rate: 3%

  • Adults aged 18+ years, ≥ 1 MDE

  • Total N: NA

  • Model features: MDD duration, time to next MDE and MDE severity, using acute and continuation phases of treatment

  • Outcomes: years of life with disability, years of life lost, DALYs

  • 7 interventions:

    • (1)

      TCA during acute phase and 6-month continuation phase

    • (2)

      SSRI during acute phase and 6-month continuation phase

    • (3)

      CBT during acute phase and 6-month continuation phase, by a psychologist or psychiatrist, public or private setting, individual or group therapy

    • (4)

      Bibliotherapy during acute phase

    • (5)

      Maintenance with TCA for 5 years following acute MDE

    • (6)

      Maintenance with SSRI for 5 years following acute MDE

    • (7)

      Maintenance with CBT with booster sessions over 5 years following acute MDE

  • Control: NA

  • CBT: 12 sessions during acute phase

  • Total years of life lost, in thousands, for 7 interventions:

    • (1)

      2.1

    • (2)

      2.1

    • (3)

      3.0

    • (4)

      0.3

    • (5)

      21

    • (6)

      22

    • (7)

      23

  • Currency, cost year: AUD, 2000

  • Total costs, in millions, 7 interventions:

    • (1)

      $51

    • (2)

      $120

    • (3)

      $21 (group CBT, public setting) to $130 (individual CBT, public or private setting, psychiatrist)

    • (4)

      $1.4

    • (5)

      $640

    • (6)

      $1,900

    • (7)

      $67 (group CBT, public setting) to $540 (individual CBT, private setting, psychiatrist)

  • Base case analysis, health system perspective: bibliotherapy, group CBT, individual CBT by psychologist on public salary, and TCA have ICERs below $10,000/DALY

  • Maintenance treatment with SSRIs is the most expensive option: ICER $20,000/DALY

Heuzenroeder et al, 2004, Australia55
  • Type of economic analysis: cost-effectiveness analysis

  • Study design: decision analytic (modelling) analysis

  • Perspective: Australia, health system perspective including indirect costs

  • Time horizon: 12 months

  • Discount rate: 0%

  • Adults 18+ years with GAD

  • Total N: NA

  • Outcomes: years of life with disability, years of life lost, DALYs

  • 5 interventions:

    • (1)

      CBT by psychologist, private setting

    • (2)

      CBT by psychologist, public setting

    • (3)

      CBT by psychiatrist, private setting

    • (4)

      CBT by psychiatrist, public setting

    • (5)

      SNRI (venlafaxine, 75 or 150 mg/day)

  • Comparator: current practice, consultation with mental health provider, based on national data

  • CBT: acute phase, 12 1-hour sessions

Total DALYs compared with current practice:
  • (1)

    CBT, private psychologist: 7,200

  • (2)

    CBT, public psychologist: 7,200

  • (3)

    CBT, private psychiatrist: 7,200

  • (4)

    CBT, public psychiatrist: 7,200

  • (5)

    SNRI: 3,300

  • Currency, cost year: AUD, 2000

  • Total costs, in millions:

    • (1)

      CBT, private psychologist: $140

    • (2)

      CBT, public psychologist: $50

    • (3)

      CBT, private psychiatrist: $170

    • (4)

      CBT, public psychiatrist: $160

    • (5)

      SNRI: $77

  • Base case analysis, health system perspective, vs. current practice, ICER ($ thousands/DALYs):

    • (1)

      CBT, private psychologist: $28

    • (2)

      CBT, public psychologist: $12

    • (3)

      CBT, private psychiatrist: $32

    • (4)

      CBT, public psychiatrist: $31

    • (5)

      SNRI: $30

Abbreviations: CBT, cognitive behavioural therapy; DALY, disability-adjusted life-year; GAD, general anxiety disorder; ICER, incremental cost-effectiveness ratio; MDD, major depressive disorder; MDE, major depressive episode; NA, not applicable; NHS, National Health Service; NR, not reported; QALY, quality-adjusted life-year; SD, standard deviation; SNRI, serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.